BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2427476)

  • 1. Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.
    Peleg L; Slor H; Cordova T; Ayalon D; Legum C; Rudick A
    Isr J Med Sci; 1986; 22(3-4):215-9. PubMed ID: 2427476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
    Schlosser H; Greiff R
    Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-fetoprotein: II. Clinical evaluation of two automated immunoassays for maternal serum screening.
    Cate JC; Gadsden RH
    Ann Clin Lab Sci; 1991; 21(4):254-7. PubMed ID: 1713436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
    Gadsden RH; Cate JC
    Ann Clin Lab Sci; 1991; 21(4):246-53. PubMed ID: 1713435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solid-phase immunoenzyme analysis of alpha-fetoprotein in human blood serum].
    Shevtsova AI; Demchenko TV; Lapa TV
    Lab Delo; 1990; (5):52-5. PubMed ID: 1695975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antenatal screening for neural tube defect by measuring alphafetoprotein in dried blood eluates (author's transl)].
    Augier D; Dutau G; Petrus M; Grandjean H; Pontonnier G; Rochiccioli P
    Arch Fr Pediatr; 1981 Dec; 38(10):757-60. PubMed ID: 6174100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of an ELISA with a RIA method for serum alpha-fetoprotein determination in screening for fetal neural tube defects.
    Barlow RD; Thompson SG; Cuckle HS; Wald NJ; Voller A
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():334-9. PubMed ID: 2431649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data from an alpha-fetoprotein pilot screening program in Maine.
    Haddow JE; Kloza EM; Smith DE; Knight GJ
    Obstet Gynecol; 1983 Nov; 62(5):556-60. PubMed ID: 6194484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values.
    Evans MI; Llurba E; Landsberger EJ; O'Brien JE; Harrison HH
    Obstet Gynecol; 2004 Mar; 103(3):474-9. PubMed ID: 14990409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal testing for maternal serum alpha-fetoprotein.
    Schwager EJ; Weiss BD
    Am Fam Physician; 1987 Apr; 35(4):169-74. PubMed ID: 2436465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.